Form 144 - Report of proposed sale of securities:
SEC Accession No. 0000950170-24-085753
Filing Date
2024-07-23
Accepted
2024-07-23 17:17:53
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html 144  
1 primary_doc.xml 144 3513
  Complete submission text file 0000950170-24-085753.txt   4947
Mailing Address 215 FIRST STREET, SUITE 440 CAMBRIDGE MA 02142
Business Address
Horobin Joanna (Reporting) CIK: 0001560959 (see all company filings)

Type: 144

Mailing Address 500 NORTH BEACON STREET, 4TH FLOOR WATERTOWN MA 02472
Business Address 500 NORTH BEACON STREET, 4TH FLOOR WATERTOWN MA 02472 857-285-5314
Kymera Therapeutics, Inc. (Subject) CIK: 0001815442 (see all company filings)

EIN.: 812992166 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 144 | Act: 33 | File No.: 001-39460 | Film No.: 241135468
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)